#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital ectodermal dysplasia KBG syndrome Skin cancer Glomerulonephritis acute Granulomatosis with polyangiitis Neuroendocrine carcinoma of the skin Thalassaemia Paraganglion neoplasm Neurofibromatosis Acquired haemophilia Diffuse large B-cell lymphoma Non-Hodgkin's lymphoma refractory Acute myeloid leukaemia Infantile spasms Follicle centre lymphoma follicular grade I, II – III More trials…

    Learn about Rare Diseases

    Isodicentric chromosome 15 syndrome – Life with Disease Nodal marginal zone B-cell lymphoma – Diagnostics Castleman’s disease Advanced systemic mastocytosis – Basic Information Turner’s syndrome – Diagnostics Paraneoplastic neurological syndrome – Diagnostics Erdheim-Chester disease – Basic Information Alport’s syndrome – Basic Information Propionic acidaemia – Life with Disease Langerhans cell sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Entinostat Munc-T3 Bio89-100 Povorcitinib Fremanezumab Frexalimab Temsirolimus Cd19-Car_Lenti_Allo Galunisertib Sodium Phenylbutyrate Tamuzimod Acetate Gen1053 FRUQUINTINIB Asciminib Anhydrous Cyclophosphamide Clofarabine Abelacimab Suxamethonium Chloride Gentamicin Pemafibrate More therapies…

    Learn about Your Condition

    Uveitis Rectal cancer stage III Aphthous ulcer Metastases to meninges Hypopituitarism Hot flush Gouty arthritis Skin papilloma Von Hippel-Lindau disease Cholangiosarcoma Pain Palmoplantar pustulosis CADASIL Labour induction Hypotension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Stereotactic Cisternal Lavage Therapy for Patients with Aneurysmal Subarachnoid Hemorrhage Using Urokinase, Nimodipine, and a Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nimodipine
    • Urokinase
    • Calcium Chloride Dihydrate
    Germany

  • Study on STC-1010 and Drug Combination for Patients with Advanced or Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Hct116-A
    • Hct116-B
    Belgium France

  • A Study of Levetiracetam for Prevention and Treatment of Delirium in Adult ICU Patients with Septic Shock

    Recruiting

    3 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Levetiracetam
    • Sodium Chloride
    France

  • Study on the Effectiveness and Safety of IgM-Enriched Immunoglobulin Therapy for Patients with Septic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Immunoglobulin A
    • Immunoglobulin G
    • Immunoglobulin M
    Italy

  • Study on the Effects of Ozanimod on Inflammation in Patients with Relapsing Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Progressive relapsing multiple sclerosis
    • Relapsing-remitting multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Ozanimod
    Italy

  • Study Comparing FOLFIRI with Cetuximab or Bevacizumab for First-Line Treatment in Patients with Metastatic Colorectal Cancer and Specific Genetic Profiles

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Cetuximab
    Italy
Previous Page
1 … 411 412 413 414 415 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!